Long-Term Onyx Implant Follow-Up, Labeling Conditions Stipulated By Panel
This article was originally published in The Gray Sheet
Executive Summary
The FDA Neurological Devices Panel's cautious endorsement of Micro Therapeutics, Inc.'s Onyx LES liquid embolic system underscores the dearth of technologies available to treat brain arteriovenous malformations